Shareholders of Walgreens Boots Alliance overwhelmingly approved the drugstore chain's $10 billion acquisition by private ...

Walgreens Boots Alliance shareholders gave the thumbs up to the private-equity buyout by Sycamore Partners, with about 96% of ...

The buyout, which will take the drugstore chain private for the first time in nearly a century, will give it more flexibility ...

Walgreens Boots Alliance (WBA) announced that at the Company’s Special Meeting of Shareholders, WBA shareholders approved the previously announced acquisition of the Company by entities affiliated ...

News that Walgreens quarterly loss was better than expected and pharmacy sales were rising bodes well for a turnaround under future ownership of Sycamore Partners.

Walgreens' $10B sale to Sycamore Partners ends a long decline for one of Chicago’s most iconic companies — and raises questions about what comes next.

Walgreens Boots Alliance (WBA) said on Friday that the struggling drug retailer’s shareholders approved its $10 billion ...

Walgreens Boots Alliance (NASDAQ: WBA) is one of the largest pharmacy retailers in the United States. As management looks to ...

The drugstore industry is facing competition from the likes of Amazon.com Inc., as well as pressure on pharmacy-reimbursement ...

Pharmacy chain Walgreens Boots Alliance (NASDAQ:WBA) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 7.2% year on year to $38.99 billion. Its non-GAAP profit of $0.

Earnings Results Walgreens’ U.S. retail sales remain weak, but here’s why the stock is rising Walgreens Boots Alliance continues to see weakness in U.S. front-end sales, says Chief Executive ...

Walgreens is something of a special situations play at this point. Since the buyout price is only a few percentage points above the current stock price, it probably isn't worth buying for most ...